Liquidia Corporation - stock earnings
LQDA Upcoming estimated earnings
Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
---|---|---|---|---|
May 2, 2024 BeforeMarket | - / -0.3200000000 | - | - / 4.5 million | - |
LQDA Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | -27.5 million USD | 4.5 million USD |
2023Q3 | -15.8 million USD | 3.7 million USD |
2023Q2 | -23.5 million USD | 4.8 million USD |
2023Q1 | -13.1 million USD | 4.5 million USD |
2022Q4 | -6.0 million USD | 5.4 million USD |
2022Q3 | -9.4 million USD | 3.2 million USD |
2022Q2 | -9.4 million USD | 3.9 million USD |
2022Q1 | -15.9 million USD | 3.5 million USD |
2021Q4 | -11.6 million USD | 3.2 million USD |
2021Q3 | -7.3 million USD | 3.2 million USD |
2021Q2 | -6.6 million USD | 3.4 million USD |
2021Q1 | -9.2 million USD | 3.1 million USD |
2020Q4 | -16.1 million USD | 739628 USD |
2020Q3 | -15.0 million USD | ? USD |
2020Q2 | -13.9 million USD | ? USD |
2020Q1 | -14.8 million USD | ? USD |
2019Q4 | -14.5 million USD | -120 USD |
2019Q3 | -13.4 million USD | ? USD |
2019Q2 | -5.9 million USD | 8.1 million USD |
2019Q1 | -13.8 million USD | ? USD |
2018Q4 | -9.7 million USD | 568402 USD |
2018Q3 | -9.7 million USD | 169730 USD |
2018Q2 | -6.3 million USD | 1.0 million USD |
2018Q1 | -27.5 million USD | 925970 USD |
2017Q4 | 8.2 million USD | 1.8 million USD |
2017Q3 | -19.2 million USD | 1.8 million USD |
2017Q2 | -8.3 million USD | 2.0 million USD |
2017Q1 | -9.8 million USD | 1.6 million USD |
2016Q4 | -15.9 million USD | 13.2 million USD |
LQDA Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -78.5 million USD | 17.5 million USD |
2022 | -38.4 million USD | 15.9 million USD |
2021 | -29.8 million USD | 12.9 million USD |
2020 | -57.5 million USD | 739628 USD |
2019 | -46.4 million USD | 8.1 million USD |
2018 | -53.1 million USD | 2.7 million USD |
2017 | -29.2 million USD | 7.3 million USD |
2016 | -15.9 million USD | 13.2 million USD |
LQDA
Price: $13.17
52 week price:
Earnings Per Share: -1.21 USD
P/E Ratio: -16.82
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 65756
Market Capitalization: 1.0 billion